Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer stem cell-derived extracellular vesicles preferentially target MHC-II-macrophages and PD1+ T cells in the tumor microenvironment. | PLoS One | 2023 | 36735677 | PubTator, text mining | PubMed |
| Integrated Whole-Exome and Transcriptome Sequencing Indicated Dysregulation of Cholesterol Metabolism in Eyelid Sebaceous Gland Carcinoma. | Transl Vis Sci Technol | 2023 | 36735267 | PubTator, text mining | PubMed |
| Identification of a polyamine-related signature and six novel prognostic biomarkers in oral squamous cell carcinoma. | Front Mol Biosci | 2023 | 36733434 | PubTator, text mining | PubMed |
| Glypican-4 regulated actin cytoskeletal reorganization in glucocorticoid treated trabecular meshwork cells and involvement of Wnt/PCP signaling. | J Cell Physiol | 2023 | 36727620 | PubTator, text mining | PubMed |
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues. | PeerJ | 2023 | 36721777 | PubTator, text mining | PubMed |
| Novel Genetic Variants Associated with Chronic Kidney Disease Progression. | J Am Soc Nephrol | 2023 | 36720675 | PubTator, text mining | PubMed |
| Mutational Landscape of Normal Human Skin: Clues to Understanding Early-Stage Carcinogenesis in Keratinocyte Neoplasia. | J Invest Dermatol | 2023 | 36716918 | PubTator, text mining | PubMed |
| Identification of hub genes involved in cisplatin resistance in head and neck cancer. | J Genet Eng Biotechnol | 2023 | 36715825 | PubTator, text mining | PubMed |
| Application of digital pathology and machine learning in the liver, kidney and lung diseases. | J Pathol Inform | 2023 | 36714454 | PubTator, text mining | PubMed |
| Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer. | Medicine (Baltimore) | 2023 | 36705391 | PubTator, text mining | PubMed |
| APOBEC mutagenesis is a common process in normal human small intestine. | Nat Genet | 2023 | 36702998 | PubTator, text mining | PubMed |
| A ferroptosis-related prognostic model with excellent clinical performance based on the exploration of the mechanism of oral squamous cell carcinoma progression. | Sci Rep | 2023 | 36702843 | PubTator, text mining | PubMed |
| Deciphering the multi-scale, quantitative cis-regulatory code. | Mol Cell | 2023 | 36693380 | PubTator, text mining | PubMed |
| Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer. | Clin Cancer Res | 2023 | 36693175 | PubTator, text mining | PubMed |
| The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. | J Clin Med | 2023 | 36675550 | PubTator, text mining | PubMed |
| The RNA-Binding Protein SMN as a Novel Player in Laryngeal Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 36675308 | PubTator, text mining | PubMed |
| The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. | Int J Mol Sci | 2023 | 36675020 | PubTator, text mining | PubMed |
| Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 36674979 | PubTator, text mining | PubMed |
| Research Trends of Vitamin D Metabolism Gene Polymorphisms Based on a Bibliometric Investigation. | Genes (Basel) | 2023 | 36672957 | PubTator, text mining | PubMed |
| Escape from Cellular Senescence Is Associated with Chromosomal Instability in Oral Pre-Malignancy. | Biology (Basel) | 2023 | 36671795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=45